Home > Qtrly Results > INDO US BIOTECH

INDO US BIOTECH
Quarterly Results Analysis [Sep2024]

INDO US BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Quarterly Results

Standalone Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
Audited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
Audited
Revenues ₹22 Cr ₹25 Cr ₹16 Cr ₹22 Cr ₹16 Cr ₹19 Cr ₹18 Cr ₹16 Cr
Expenses ₹17 Cr ₹21 Cr ₹15 Cr ₹18 Cr ₹13 Cr ₹16 Cr ₹15 Cr ₹13 Cr
Operating Income ₹5 Cr ₹4 Cr ₹1 Cr ₹4 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹2 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹4 Cr ₹3 Cr ₹1 Cr ₹4 Cr ₹2 Cr ₹2 Cr ₹3 Cr ₹1 Cr
Profit After Tax ₹4 Cr ₹3 Cr ₹1 Cr ₹4 Cr ₹2 Cr ₹2 Cr ₹3 Cr ₹1 Cr
EPS ₹2.17 ₹1.58 ₹0.26 ₹1.84 ₹0.83 ₹1.18 ₹1.38 ₹0.68
Industry Peers & Returns1W1M1Y
INDO US BIOTECH 2.4% 9.4% 9.8%
BOMBAY BURMAH TRADING CORPORATION -1.1% -6.3% 66.4%
KAVERI SEED COMPANY 0.4% -2% 39.6%
VENKYS (INDIA) 0% 0.1% -15.2%
BOMBAY SUPER HYBRID SEEDS -4.4% -13.3% -38%
TIERRA AGROTECH 6.5% 3.3% -36.9%
NATH BIOGENES (INDIA) 2.5% -9.8% -14.7%
MANGALAM SEEDS -7.4% -13.4% -10.8%
SHREE OSWAL SEEDS AND CHEMICALS -4.6% -13.3% -62.1%

INDO US BIOTECH Quarterly Revenues

Revenues
Q-o-Q

-10.30 %

Y-o-Y

40.21 %

Quarters Revenues % Change
Sep2024 ₹22 Cr
-10.30
Jun2024 ₹25 Cr
56.78
Mar2024 ₹16 Cr
-28.71
Dec2023 ₹22 Cr
39.84
Sep2023 ₹16 Cr
-17.39
Jun2023 ₹19 Cr
5.70
Mar2023 ₹18 Cr
16.82
Dec2022 ₹16 Cr -

INDO US BIOTECH Quarterly Operating Profit

Operating Profit
Q-o-Q

38.77 %

Y-o-Y

97.46 %

Quarters Operating Profit % Change
Sep2024 ₹5 Cr
38.77
Jun2024 ₹4 Cr
280.52
Mar2024 ₹1 Cr
-77.12
Dec2023 ₹4 Cr
63.45
Sep2023 ₹3 Cr
-13.27
Jun2023 ₹3 Cr
-3.33
Mar2023 ₹3 Cr
50.71
Dec2022 ₹2 Cr -
Operating Margins
Q-o-Q

54.72 %

Y-o-Y

40.85 %

Quarters Operating Margin% % Change
Sep2024 23.1%
54.72
Jun2024 14.93%
142.76
Mar2024 6.15%
-67.92
Dec2023 19.17%
16.89
Sep2023 16.4%
4.99
Jun2023 15.62%
-8.55
Mar2023 17.08%
29.00
Dec2022 13.24% -

INDO US BIOTECH Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

37.58 %

Y-o-Y

161.08 %

Quarters Profit After Tax % Change
Sep2024 ₹4 Cr
37.58
Jun2024 ₹3 Cr
504.77
Mar2024 ₹1 Cr
-85.78
Dec2023 ₹4 Cr
120.66
Sep2023 ₹2 Cr
-29.60
Jun2023 ₹2 Cr
-14.46
Mar2023 ₹3 Cr
102.26
Dec2022 ₹1 Cr -
PAT Margins
Q-o-Q

53.35 %

Y-o-Y

86.17 %

Quarters PAT Margin(%) % Change
Sep2024 19.66 %
53.35
Jun2024 12.82 %
286.14
Mar2024 3.32 %
-80.07
Dec2023 16.66 %
57.77
Sep2023 10.56 %
-14.77
Jun2023 12.39 %
-19.07
Mar2023 15.31 %
73.19
Dec2022 8.84 % -

INDO US BIOTECH Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

37.34 %

Y-o-Y

161.45 %

Quarters EPS % Change
Sep2024 ₹2.17
37.34
Jun2024 ₹1.58
507.69
Mar2024 ₹0.26
-85.87
Dec2023 ₹1.84
121.69
Sep2023 ₹0.83
-29.66
Jun2023 ₹1.18
-14.49
Mar2023 ₹1.38
102.94
Dec2022 ₹0.68 -

You may also like the below Video Courses